| A potential therapeutic role for angiotensin-converting enzyme 2 in human pulmonary arterial hypertension AR Hemnes, A Rathinasabapathy, EA Austin, EL Brittain, EJ Carrier, ... European Respiratory Journal 51 (6), 2018 | 214 | 2018 |
| Diminazene attenuates pulmonary hypertension and improves angiogenic progenitor cell functions in experimental models V Shenoy, A Gjymishka, YP Jarajapu, Y Qi, A Afzal, K Rigatto, AJ Ferreira, ... American journal of respiratory and critical care medicine 187 (6), 648-657, 2013 | 172 | 2013 |
| Oral delivery of angiotensin-converting enzyme 2 and angiotensin-(1-7) bioencapsulated in plant cells attenuates pulmonary hypertension V Shenoy, KC Kwon, A Rathinasabapathy, S Lin, G Jin, C Song, P Shil, ... Hypertension 64 (6), 1248-1259, 2014 | 165 | 2014 |
| In vitro glucose uptake activity of Aegles marmelos and Syzygium cumini by activation of Glut-4, PI3 kinase and PPARγ in L6 myotubes R Anandharajan, S Jaiganesh, NP Shankernarayanan, RA Viswakarma, ... Phytomedicine 13 (6), 434-441, 2006 | 135 | 2006 |
| Selective activation of angiotensin AT2 receptors attenuates progression of pulmonary hypertension and inhibits cardiopulmonary fibrosis E Bruce, V Shenoy, A Rathinasabapathy, A Espejo, A Horowitz, A Oswalt, ... British Journal of Pharmacology 172 (9), 2219-2231, 2015 | 92 | 2015 |
| Isolation and characterization of endothelial-to-mesenchymal transition cells in pulmonary arterial hypertension T Suzuki, EJ Carrier, MH Talati, A Rathinasabapathy, X Chen, ... American Journal of Physiology-Lung Cellular and Molecular Physiology 314 (1 …, 2018 | 90 | 2018 |
| Upregulation of GLUT-4 and PPARγ by an isoflavone from Pterocarpus marsupium on L6 myotubes: a possible mechanism of action R Anandharajan, K Pathmanathan, NP Shankernarayanan, ... Journal of ethnopharmacology 97 (2), 253-260, 2005 | 81 | 2005 |
| The selective angiotensin II type 2 receptor agonist, compound 21, attenuates the progression of lung fibrosis and pulmonary hypertension in an experimental model of bleomycin … A Rathinasabapathy, A Horowitz, K Horton, A Kumar, S Gladson, T Unger, ... Frontiers in physiology 9, 180, 2018 | 59 | 2018 |
| Therapeutic potential of adipose stem cell‐derived conditioned medium against pulmonary hypertension and lung fibrosis A Rathinasabapathy, E Bruce, A Espejo, A Horowitz, DR Sudhan, A Nair, ... British Journal of Pharmacology 173 (19), 2859-2879, 2016 | 59 | 2016 |
| Involvement of neuroinflammation in the pathogenesis of monocrotaline-induced pulmonary hypertension RK Sharma, AC Oliveira, S Kim, K Rigatto, J Zubcevic, ... Hypertension 71 (6), 1156-1163, 2018 | 39 | 2018 |
| rhACE2 therapy modifies bleomycin-induced pulmonary hypertension via rescue of vascular remodeling A Rathinasabapathy, AJ Bryant, T Suzuki, C Moore, S Shay, S Gladson, ... Frontiers in physiology 9, 271, 2018 | 34 | 2018 |
| Stem cell therapy restores viscoelastic properties of myocardium in rat model of hypertension A Rubiano, Y Qi, D Guzzo, A Rathinasabapathy, K Rowe, C Pepine, ... Journal of the mechanical behavior of biomedical materials 59, 71-77, 2016 | 20 | 2016 |
| Thromboxane–prostanoid receptor signaling drives persistent fibroblast activation in pulmonary fibrosis T Suzuki, JA Kropski, J Chen, EJ Carrier, X Chen, TP Sherrill, NI Winters, ... American Journal of Respiratory and Critical Care Medicine 206 (5), 596-607, 2022 | 13 | 2022 |
| KCNK3 mutation causes altered immune function in pulmonary arterial hypertension patients and mouse models JD West, ED Austin, EM Rizzi, L Yan, H Tanjore, AL Crabtree, CS Moore, ... International journal of molecular sciences 22 (9), 5014, 2021 | 13 | 2021 |
| Rapid disease progress in a PVOD patient carrying a novel EIF2AK4 mutation: a case report X Zeng, F Chen, A Rathinasabapathy, T Li, ... BMC Pulmonary Medicine 20, 1-5, 2020 | 10 | 2020 |
| Differential serum lipid distribution in IPAH and CHD-PAH patients J Chen, A Rathinasabapathy, J Luo, X Yang, P Luo, Y Chen, Z Li, J Li Respiratory Medicine 191, 106711, 2022 | 7 | 2022 |
| Association of cardiac injury with hypertension in hospitalized patients with COVID-19 in China X Zeng, A Rathinasabapathy, D Liu, L Zha, X Liu, Y Tang, F Li, W Lin, ... Scientific reports 11 (1), 22389, 2021 | 6 | 2021 |
| Expression of a human caveolin-1 mutation in mice drives inflammatory and metabolic defect-associated pulmonary arterial hypertension A Rathinasabapathy, C Copeland, A Crabtree, EJ Carrier, C Moore, ... Frontiers in Medicine 7, 540, 2020 | 6 | 2020 |
| 7A. 04: DYSFUNCTIONAL ADIPOSE STEM CELL IS LINKED TO OBESITY, ELEVATED INFLAMMATORY CYTOKINES AND RESISTANT HYPERTENSION Y Qi, A Rathinasabapathy, T Huo, J Zhang, H Shang, A Katz, M Katovich, ... Journal of Hypertension 33, e90, 2015 | 5 | 2015 |
| 18F9 (4-(3, 6-bis (ethoxycarbonyl)-4, 5, 6, 7-tetrahydrothieno (2, 3-c) pyridin-2-ylamino)-4-oxobutanoic acid) enhances insulin-mediated glucose uptake in vitro and exhibits … R Anandharajan, SG Sayyed, LS Doshi, P Dixit, PG Chandak, AV Dixit, ... Metabolism 58 (10), 1503-1516, 2009 | 4 | 2009 |
